Global Information
회사소개 | 문의

세계의 동물 통증 관리 시장 예측(-2023년) : 의약품별(NSAID, 오피오이드), 기기별, 관절통별(골관절염, 근골격장애), 수술후 통증, 암

Veterinary Pain Management Market by Product (Drugs (NSAIDs, Opioids), Device (Laser, Electromagnetic)), Application (Osteoarthritis, Cancer), Animal Type (Dog, Cat, Horse, Cattle), Distribution Channel (Hospital, Pharmacy) - Global Forecast to 2023

리서치사 MarketsandMarkets
발행일 2018년 04월 상품 코드 630093
페이지 정보 영문 239 Pages
가격
US $ 5,650 ₩ 6,377,700 PDF by E-mail (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 6,650 ₩ 7,506,500 PDF by E-mail (5-user License) help
동일 사업장 내 5명까지 공유하여 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 8,150 ₩ 9,199,700 PDF by E-mail (Corporate License) help
기업 내 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없지만, 동일 국가의 동일 사업장에 한정되며 해외지점 등은 포함되지 않습니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 10,000 ₩ 11,288,000 PDF by E-mail (Global License) help
동일 기업의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없습니다. 100% 자회사는 동일 기업으로 간주됩니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.


세계의 동물 통증 관리 시장 예측(-2023년) : 의약품별(NSAID, 오피오이드), 기기별, 관절통별(골관절염, 근골격장애), 수술후 통증, 암 Veterinary Pain Management Market by Product (Drugs (NSAIDs, Opioids), Device (Laser, Electromagnetic)), Application (Osteoarthritis, Cancer), Animal Type (Dog, Cat, Horse, Cattle), Distribution Channel (Hospital, Pharmacy) - Global Forecast to 2023
발행일 : 2018년 04월 페이지 정보 : 영문 239 Pages

한글목차

세계의 동물 통증 관리 시장은 2018년 11억 3,000만 달러에서 2023년까지 16억 6,000만 달러에 이를 것으로 예측되며, 2018-2023년간 8.0%의 연평균 성장률(CAGR)을 나타낼 전망입니다. 애완동물 소유주 증가, 선진 경제국가의 수의사 수와 소득수준 증가, 통증·염증을 수반하는 동물질환 유병률 증가, 동물 의료비 상승에 의한 애완동물 보험 가입 증가는 동물 통증 관리 시장의 성장을 촉진할 것으로 예측됩니다. 그러나, 애완동물 케어 비용 증가는 동물 통증 관리 시장의 성장을 어느 정도 억제할 가능성이 있습니다.

세계의 동물 통증 관리(Veterinary Pain Management) 시장에 대해 조사했으며, 시장 개요, 제품·용도·동물 종류·유통채널·지역별 동향과 예측, 주요 시장 진출기업 개요 등의 정보를 정리하여 전해드립니다.

제1장 서론

제2장 조사 방법

제3장 주요 요약

제4장 프리미엄 인사이트

  • 동물 통증 관리 : 시장 개요
  • 아시아태평양의 동물 통증 관리 시장 : 용도별
  • 동물 통증 관리 시장 지역별 개요
  • 동물 통증 관리 시장 : 신흥국가 vs. 선진국가
  • 동물 통증 관리 시장 : 지역별

제5장 시장 개요

  • 서론
  • 시장 역학
    • 성장 촉진요인
    • 성장 저해요인
    • 기회
    • 해결해야 할 과제
  • 규제 분석

제6장 동물 통증 관리 시장 : 제품별

  • 서론
  • 의약품
    • 의약품 : 종류별
    • 의약품 : 투여 경로별
  • 기기

제7장 동물 통증 관리 시장 : 용도별

  • 서론
  • 관절통
    • 골관절염
    • 근골격 장애
  • 수술후 통증
  • 기타 용도

제8장 동물 통증 관리 시장 : 동물 종류별

  • 서론
  • 애완동물
    • 고양이
    • 기타
  • 가축
    • 돼지
    • 기타

제9장 동물 통증 관리 시장 : 유통채널별

  • 서론
  • 동물병원 및 진료소
  • 약국

제10장 동물 통증 관리 시장 : 지역별

  • 서론
  • 북미
  • 유럽
  • 아시아태평양
  • 라틴아메리카
  • 중동 및 아프리카

제11장 경쟁 환경

  • 개요
  • 제품 포트폴리오 믹스
  • 성장 전략 매트릭스
  • 시장 점유율 분석
  • 경쟁 구도와 동향

제12장 기업 개요

  • BOEHRINGER INGELHEIM
  • ZOETIS
  • ELANCO
  • MERCK ANIMAL HEALTH
  • BAYER
  • VETOQUINOL
  • NORBROOK LABORATORIES
  • CEVA SANTE ANIMALE
  • DECHRA PHARMACEUTICALS
  • CHANELLE
  • K-LASER USA
  • ASSISI ANIMAL HEALTH

제13장 부록

LSH 18.05.02

LIST OF TABLES

  • TABLE 1: VETERINARY PAIN MANAGEMENT MARKET: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • TABLE 2: COMPANION ANIMAL POPULATION, BY COUNTRY, 2016 (MILLION)
  • TABLE 3: DEVELOPED ECONOMIES: NUMBER OF VETERINARY PROFESSIONALS (2012-2016)
  • TABLE 4: RECENT DEVELOPMENTS IN REGULATIONS FOR PAIN MANAGEMENT DRUGS IN THE US
  • TABLE 5: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 6: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 7: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 8: NON-STEROIDAL ANTI-INFLAMMATORY DRUGS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 9: OPIOIDS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 10: LOCAL ANESTHETICS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 11: ALPHA-2 AGONISTS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 12: DISEASE-MODIFYING OSTEOARTHRITIS DRUGS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 13: OTHER VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 14: ROUTES OF ADMINISTRATION OF MAJOR VETERINARY PAIN MANAGEMENT DRUGS
  • TABLE 15: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2016-2023 (USD MILLION)
  • TABLE 16: ORAL VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 17: PARENTERAL VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 18: TOPICAL VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 19: VETERINARY PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 20: LASER THERAPY DEVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 21: ELECTROMAGNETIC THERAPY DEVICES MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 22: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 23: VETERINARY PAIN MANAGEMENT MARKET FOR JOINT PAIN, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 24: VETERINARY PAIN MANAGEMENT MARKET FOR OSTEOARTHRITIS, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 25: VETERINARY PAIN MANAGEMENT MARKET FOR MUSCULOSKELETAL DISORDERS, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 26: VETERINARY PAIN MANAGEMENT MARKET FOR POSTOPERATIVE PAIN, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 27: VETERINARY PAIN MANAGEMENT DRUG MARKET FOR CANCER, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 28: VETERINARY PAIN MANAGEMENT MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 29: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2016-2023 (USD MILLION)
  • TABLE 30: VETERINARY PAIN MANAGEMENT FOR COMPANION ANIMALS, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 31: VETERINARY PAIN MANAGEMENT MARKET FOR COMPANION ANIMALS, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 32: PET DOG POPULATION, BY COUNTRY, 2010-2016 (MILLION)
  • TABLE 33: VETERINARY PAIN MANAGEMENT MARKET FOR DOGS, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 34: VETERINARY PAIN MANAGEMENT MARKET FOR CATS, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 35: PET HORSE POPULATION, BY COUNTRY, 2012-2016 (THOUSANDS)
  • TABLE 36: VETERINARY PAIN MANAGEMENT MARKET FOR HORSES, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 37: VETERINARY PAIN MANAGEMENT MARKET FOR OTHER COMPANION ANIMALS, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 38: VETERINARY PAIN MANAGEMENT FOR LIVESTOCK, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 39: VETERINARY PAIN MANAGEMENT MARKET FOR LIVESTOCK, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 40: CATTLE POPULATION, BY COUNTRY, 2012-2016 (THOUSANDS)
  • TABLE 41: VETERINARY PAIN MANAGEMENT MARKET FOR CATTLE, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 42: VETERINARY PAIN MANAGEMENT MARKET FOR SWINE, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 43: VETERINARY PAIN MANAGEMENT MARKET FOR OTHER LIVESTOCK, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 44: VETERINARY PAIN MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2016-2023 (USD MILLION)
  • TABLE 45: NUMBER OF PRIVATE CLINICAL PRACTICES, BY COUNTRY, 2012 VS. 2016
  • TABLE 46: VETERINARY PAIN MANAGEMENT MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 47: VETERINARY PAIN MANAGEMENT MARKET FOR PHARMACY, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 48: VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 49: NORTH AMERICA: VETERINARY PAIN MANAGEMENT MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 50: NORTH AMERICA: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 51: NORTH AMERICA: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 52: NORTH AMERICA: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2016-2023 (USD MILLION)
  • TABLE 53: NORTH AMERICA: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 54: NORTH AMERICA: VETERINARY PAIN MANAGEMENT MARKET FOR JOINT PAIN, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 55: NORTH AMERICA: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2016-2023 (USD MILLION)
  • TABLE 56: NORTH AMERICA: VETERINARY PAIN MANAGEMENT MARKET FOR COMPANION ANIMALS, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 57: NORTH AMERICA: VETERINARY PAIN MANAGEMENT MARKET FOR LIVESTOCK, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 58: NORTH AMERICA: VETERINARY PAIN MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2016-2023 (USD MILLION)
  • TABLE 59: US: NUMBER OF HOUSEHOLDS THAT OWNED PETS, BY TYPE OF COMPANION ANIMAL, 2010 VS. 2016 (MILLION)
  • TABLE 60: US: PRIVATE CLINICAL PRACTICE, BY ANIMAL TYPE, 2012 VS. 2017
  • TABLE 61: US: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 62: US: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 63: US: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2016-2023 (USD MILLION)
  • TABLE 64: US: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 65: US: VETERINARY PAIN MANAGEMENT MARKET FOR JOINT PAIN, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 66: US: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2016-2023 (USD MILLION)
  • TABLE 67: US: VETERINARY PAIN MANAGEMENT MARKET FOR COMPANION ANIMALS, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 68: US: VETERINARY PAIN MANAGEMENT MARKET FOR LIVESTOCK, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 69: US: VETERINARY PAIN MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2016-2023 (USD MILLION)
  • TABLE 70: COMPANION ANIMAL POPULATION IN CANADA, 2011 VS. 2016 (MILLION)
  • TABLE 71: CANADA: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 72: CANADA: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 73: CANADA: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2016-2023 (USD MILLION)
  • TABLE 74: CANADA: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 75: CANADA: VETERINARY PAIN MANAGEMENT MARKET FOR JOINT PAIN, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 76: CANADA: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2016-2023 (USD MILLION)
  • TABLE 77: CANADA: VETERINARY PAIN MANAGEMENT MARKET FOR COMPANION ANIMALS, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 78: CANADA: VETERINARY PAIN MANAGEMENT MARKET FOR LIVESTOCK, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 79: CANADA: VETERINARY PAIN MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2016-2023 (USD MILLION)
  • TABLE 80: EUROPE: VETERINARY PAIN MANAGEMENT MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 81: EUROPE: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 82: EUROPE: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 83: EUROPE: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2016-2023 (USD MILLION)
  • TABLE 84: EUROPE: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 85: EUROPE: VETERINARY PAIN MANAGEMENT MARKET FOR JOINT PAIN, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 86: EUROPE: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2016-2023 (USD MILLION)
  • TABLE 87: EUROPE: VETERINARY PAIN MANAGEMENT MARKET FOR COMPANION ANIMALS, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 88: EUROPE: VETERINARY PAIN MANAGEMENT MARKET FOR LIVESTOCK, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 89: EUROPE: VETERINARY PAIN MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2016-2023 (USD MILLION)
  • TABLE 90: GERMANY: COMPANION ANIMAL POPULATION, (2010-2016) (MILLION)
  • TABLE 91: GERMANY: NUMBER OF VETERINARIANS, BY TYPE OF PRACTICE, 2014 VS. 2016
  • TABLE 92: GERMANY: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 93: GERMANY: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 94: GERMANY: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2016-2023 (USD MILLION)
  • TABLE 95: GERMANY: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 96: GERMANY: VETERINARY PAIN MANAGEMENT MARKET FOR JOINT PAIN, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 97: GERMANY: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2016-2023 (USD MILLION)
  • TABLE 98: GERMANY: VETERINARY PAIN MANAGEMENT MARKET FOR COMPANION ANIMALS, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 99: GERMANY: VETERINARY PAIN MANAGEMENT MARKET FOR LIVESTOCK, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 100: GERMANY: VETERINARY PAIN MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2016-2023 (USD MILLION)
  • TABLE 101: UK: COMPANION ANIMAL POPULATION, (2010-2016) (MILLION)
  • TABLE 102: UK: NUMBER OF VETERINARIANS, BY TYPE OF PRACTICE, 2014 VS. 2016
  • TABLE 103: UK: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 104: UK: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 105: UK: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2016-2023 (USD MILLION)
  • TABLE 106: UK: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 107: UK: VETERINARY PAIN MANAGEMENT MARKET FOR JOINT PAIN, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 108: UK: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2016-2023 (USD MILLION)
  • TABLE 109: UK: VETERINARY PAIN MANAGEMENT MARKET FOR COMPANION ANIMALS, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 110: UK: VETERINARY PAIN MANAGEMENT MARKET FOR LIVESTOCK, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 111: UK: VETERINARY PAIN MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2016-2023 (USD MILLION)
  • TABLE 112: FRANCE: COMPANION ANIMAL POPULATION, (2010-2016) (MILLION)
  • TABLE 113: FRANCE: NUMBER OF VETERINARIANS, BY TYPE OF PRACTICE, 2014 VS. 2016
  • TABLE 114: FRANCE: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 115: FRANCE: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 116: FRANCE: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2016-2023 (USD MILLION)
  • TABLE 117: FRANCE: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 118: FRANCE: VETERINARY PAIN MANAGEMENT MARKET FOR JOINT PAIN, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 119: FRANCE: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2016-2023 (USD MILLION)
  • TABLE 120: FRANCE: VETERINARY PAIN MANAGEMENT MARKET FOR COMPANION ANIMALS, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 121: FRANCE: VETERINARY PAIN MANAGEMENT MARKET FOR LIVESTOCK, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 122: FRANCE: VETERINARY PAIN MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2016-2023 (USD MILLION)
  • TABLE 123: ITALY: FOOD-PRODUCING ANIMAL POPULATION, 2010-2016 (MILLION)
  • TABLE 124: ITALY: NUMBER OF VETERINARIANS, 2012 VS. 2016
  • TABLE 125: ITALY: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 126: ITALY: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 127: ITALY: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2016-2023 (USD MILLION)
  • TABLE 128: ITALY: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 129: ITALY: VETERINARY PAIN MANAGEMENT MARKET FOR JOINT PAIN, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 130: ITALY: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2016-2023 (USD MILLION)
  • TABLE 131: ITALY: VETERINARY PAIN MANAGEMENT MARKET FOR COMPANION ANIMALS, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 132: ITALY: VETERINARY PAIN MANAGEMENT MARKET FOR LIVESTOCK, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 133: ITALY: VETERINARY PAIN MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2016-2023 (USD MILLION)
  • TABLE 134: SPAIN: FOOD-PRODUCING ANIMAL POPULATION, 2010-2016 (MILLION)
  • TABLE 135: SPAIN: NUMBER OF VETERINARIANS, 2014
  • TABLE 136: SPAIN: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 137: SPAIN: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 138: SPAIN: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2016-2023 (USD MILLION)
  • TABLE 139: SPAIN: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 140: SPAIN: VETERINARY PAIN MANAGEMENT MARKET FOR JOINT PAIN, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 141: SPAIN: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2016-2023 (USD MILLION)
  • TABLE 142: SPAIN: VETERINARY PAIN MANAGEMENT MARKET FOR COMPANION ANIMALS, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 143: SPAIN: VETERINARY PAIN MANAGEMENT MARKET FOR LIVESTOCK, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 144: SPAIN: VETERINARY PAIN MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2016-2023 (USD MILLION)
  • TABLE 145: ROE: COMPANION ANIMAL POPULATION, 2016 (MILLION)
  • TABLE 146: ROE: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 147: ROE: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 148: ROE: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2016-2023 (USD MILLION)
  • TABLE 149: ROE: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 150: ROE: VETERINARY PAIN MANAGEMENT MARKET FOR JOINT PAIN, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 151: ROE: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2016-2023 (USD MILLION)
  • TABLE 152: ROE: VETERINARY PAIN MANAGEMENT MARKET FOR COMPANION ANIMALS, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 153: ROE: VETERINARY PAIN MANAGEMENT MARKET FOR LIVESTOCK, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 154: ROE: VETERINARY PAIN MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2016-2023 (USD MILLION)
  • TABLE 155: ASIA PACIFIC: FOOD-PRODUCING ANIMAL POPULATION, (2010-2016) (MILLION)
  • TABLE 156: ASIA PACIFIC: VETERINARY PAIN MANAGEMENT MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 157: ASIA PACIFIC: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 158: ASIA PACIFIC: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 159: ASIA PACIFIC: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2016-2023 (USD MILLION)
  • TABLE 160: ASIA PACIFIC: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 161: ASIA PACIFIC: VETERINARY PAIN MANAGEMENT MARKET FOR JOINT PAIN, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 162: ASIA PACIFIC: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2016-2023 (USD MILLION)
  • TABLE 163: ASIA PACIFIC: VETERINARY PAIN MANAGEMENT MARKET FOR COMPANION ANIMALS, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 164: ASIA PACIFIC: VETERINARY PAIN MANAGEMENT MARKET FOR LIVESTOCK, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 165: ASIA PACIFIC: VETERINARY PAIN MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2016-2023 (USD MILLION)
  • TABLE 166: CHINA: FOOD-PRODUCING ANIMAL POPULATION, (2010-2016) (MILLION)
  • TABLE 167: CHINA: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 168: CHINA: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 169: CHINA: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2016-2023 (USD MILLION)
  • TABLE 170: CHINA: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 171: CHINA: VETERINARY PAIN MANAGEMENT MARKET FOR JOINT PAIN, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 172: CHINA: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2016-2023 (USD MILLION)
  • TABLE 173: CHINA: VETERINARY PAIN MANAGEMENT MARKET FOR COMPANION ANIMALS, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 174: CHINA: VETERINARY PAIN MANAGEMENT MARKET FOR LIVESTOCK, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 175: CHINA: VETERINARY PAIN MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2016-2023 (USD MILLION)
  • TABLE 176: JAPAN: FOOD-PRODUCING ANIMAL POPULATION, (2010-2016) (MILLION)
  • TABLE 177: JAPAN: NUMBER OF VETERINARIANS, 2010 VS. 2016
  • TABLE 178: JAPAN: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 179: JAPAN: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 180: JAPAN: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2016-2023 (USD MILLION)
  • TABLE 181: JAPAN: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 182: JAPAN: VETERINARY PAIN MANAGEMENT MARKET FOR JOINT PAIN, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 183: JAPAN: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2016-2023 (USD MILLION)
  • TABLE 184: JAPAN: VETERINARY PAIN MANAGEMENT MARKET FOR COMPANION ANIMALS, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 185: JAPAN: VETERINARY PAIN MANAGEMENT MARKET FOR LIVESTOCK, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 186: JAPAN: VETERINARY PAIN MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2016-2023 (USD MILLION)
  • TABLE 187: INDIA: FOOD-PRODUCING ANIMAL POPULATION (2010-2016) (MILLION)
  • TABLE 188: INDIA: NUMBER OF VETERINARIANS, 2014
  • TABLE 189: INDIA: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 190: INDIA: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 191: INDIA: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2016-2023 (USD MILLION)
  • TABLE 192: INDIA: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 193: INDIA: VETERINARY PAIN MANAGEMENT MARKET FOR JOINT PAIN, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 194: INDIA: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2016-2023 (USD MILLION)
  • TABLE 195: INDIA: VETERINARY PAIN MANAGEMENT MARKET FOR COMPANION ANIMALS, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 196: INDIA: VETERINARY PAIN MANAGEMENT MARKET FOR LIVESTOCK, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 197: INDIA: VETERINARY PAIN MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2016-2023 (USD MILLION)
  • TABLE 198: ROAPAC: FOOD PRODUCING ANIMAL POPULATION (2010-2016) (MILLION)
  • TABLE 199: ROAPAC: NUMBER OF VETERINARIANS
  • TABLE 200: ROAPAC: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 201: ROAPAC: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 202: ROAPAC: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2016-2023 (USD MILLION)
  • TABLE 203: ROAPAC: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 204: ROAPAC: VETERINARY PAIN MANAGEMENT MARKET FOR JOINT PAIN, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 205: ROAPAC: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2016-2023 (USD MILLION)
  • TABLE 206: ROAPAC: VETERINARY PAIN MANAGEMENT MARKET FOR COMPANION ANIMALS, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 207: ROAPAC: VETERINARY PAIN MANAGEMENT MARKET FOR LIVESTOCK, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 208: ROAPAC: VETERINARY PAIN MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2016-2023 (USD MILLION)
  • TABLE 209: NUMBER OF VETERINARIANS AND VETERINARY PARA-PROFESSIONALS IN LATIN AMERICAN COUNTRIES, 2010 VS 2016
  • TABLE 210: LATIN AMERICA: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 211: LATIN AMERICA: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 212: LATIN AMERICA: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2016-2023 (USD MILLION)
  • TABLE 213: LATIN AMERICA: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 214: LATIN AMERICA: VETERINARY PAIN MANAGEMENT MARKET FOR JOINT PAIN, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 215: LATIN AMERICA: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2016-2023 (USD MILLION)
  • TABLE 216: LATIN AMERICA: VETERINARY PAIN MANAGEMENT MARKET FOR COMPANION ANIMALS, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 217: LATIN AMERICA: VETERINARY PAIN MANAGEMENT MARKET FOR LIVESTOCK, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 218: LATIN AMERICA: VETERINARY PAIN MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2016-2023 (USD MILLION)
  • TABLE 219: NUMBER OF VETERINARIANS AND VETERINARY PARA-PROFESSIONALS IN THE MIDDLE EAST & AFRICA, 2010 VS 2016
  • TABLE 220: MIDDLE EAST & AFRICA: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 221: MIDDLE EAST & AFRICA: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 222: MIDDLE EAST & AFRICA: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2016-2023 (USD MILLION)
  • TABLE 223: MIDDLE EAST & AFRICA: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 224: MIDDLE EAST & AFRICA: VETERINARY PAIN MANAGEMENT MARKET FOR JOINT PAIN, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 225: MIDDLE EAST & AFRICA: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2016-2023 (USD MILLION)
  • TABLE 226: MIDDLE EAST & AFRICA: VETERINARY PAIN MANAGEMENT MARKET FOR COMPANION ANIMALS, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 227: MIDDLE EAST & AFRICA: VETERINARY PAIN MANAGEMENT MARKET FOR LIVESTOCK, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 228: MIDDLE EAST & AFRICA: VETERINARY PAIN MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2016-2023 (USD MILLION)
  • TABLE 229: KEY ACQUISITIONS, JANUARY 2014 - FEBRUARY 2018
  • TABLE 230: KEY PRODUCT LAUNCHES, JANUARY 2014- FEBRUARY 2018
  • TABLE 231: KEY AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, JANUARY 2014 - FEBRUARY 2018
  • TABLE 232: KEY EXPANSIONS, JANUARY 2014 - FEBRUARY 2018

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: PRIMARY SOURCES
  • FIGURE 3: BREAKDOWN OF PRIMARY INTERVIEWS(SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 4: BREAKDOWN OF PRIMARY INTERVIEWS(DEMAND SIDE): BY DISTRIBUTION CHANNEL, AND REGION
  • FIGURE 5: BOTTOM-UP APPROACH
  • FIGURE 6: TOP-DOWN APPROACH
  • FIGURE 7: DATA TRIANGULATION METHODOLOGY
  • FIGURE 8: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT, 2018 VS. 2023 (USD MILLION)
  • FIGURE 9: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY TYPE, 2018 VS. 2023 (USD MILLION)
  • FIGURE 10: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2018 VS. 2023 (USD MILLION)
  • FIGURE 11: VETERINARY PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2018 VS. 2023 (USD MILLION)
  • FIGURE 12: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2018 VS. 2023 (USD MILLION)
  • FIGURE 13: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2018 VS. 2023 (USD MILLION)
  • FIGURE 14: VETERINARY PAIN MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2018 VS. 2023 (USD MILLION)
  • FIGURE 15: GEOGRAPHICAL SNAPSHOT OF THE VETERINARY PAIN MANAGEMENT MARKET
  • FIGURE 16: GROWTH IN COMPANION ANIMAL ADOPTION AND INCREASING PREVALENCE OF ANIMAL DISEASES IS DRIVING MARKET GROWTH
  • FIGURE 17: CHINA ACCOUNTED FOR THE LARGEST MARKET SHARE IN 2017
  • FIGURE 18: THE US ACCOUNTED FOR THE LARGEST SHARE OF THE MARKET IN 2017
  • FIGURE 19: CHINA TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 20: ASIA PACIFIC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 21: NORTH AMERICAN PET HEALTH INSURANCE MARKET, 2012-2016 (USD MILLION)
  • FIGURE 22: DEVELOPMENT AND APPROVAL PROCESS FOR ANIMAL PHARMACEUTICAL PRODUCTS
  • FIGURE 23: APPROVAL PROCESS FOR ANIMAL PHARMACEUTICAL PRODUCTS IN EUROPE
  • FIGURE 24: DRUGS SEGMENT TO DOMINATE THE VETERINARY PAIN MANAGEMENT MARKET DURING THE FORECAST PERIOD
  • FIGURE 25: NSAIDS TO DOMINATE THE VETERINARY PAIN MANAGEMENT DRUGS MARKET DURING THE FORECAST PERIOD
  • FIGURE 26: JOINT PAIN TO DOMINATE THE VETERINARY PAIN MANAGEMENT MARKET DURING THE FORECAST PERIOD
  • FIGURE 27: COMPANION ANIMALS SEGMENT TO DOMINATE THE VETERINARY PAIN MANAGEMENT MARKET DURING THE FORECAST PERIOD
  • FIGURE 28: EUROPE: PET CAT POPULATION, BY COUNTRY, 2016 (THOUSANDS)
  • FIGURE 29: PER CAPITA PORK CONSUMPTION FROM 2006-2017 (POUNDS)
  • FIGURE 30: HOSPITALS & CLINICS FORMED THE LARGEST DISTRIBUTION CHANNEL FOR VETERINARY PAIN MANAGEMENT DRUGS AND DEVICES
  • FIGURE 31: VETERINARY PAIN MANAGEMENT MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • FIGURE 32: NORTH AMERICA: VETERINARY PAIN MANAGEMENT MARKET SNAPSHOT
  • FIGURE 33: EUROPE: VETERINARY PAIN MANAGEMENT MARKET SNAPSHOT
  • FIGURE 34: APAC: VETERINARY PAIN MANAGEMENT MARKET SNAPSHOT
  • FIGURE 35: KEY DEVELOPMENTS IN THE VETERINARY PAIN MANAGEMENT MARKET BETWEEN JANUARY 2014 AND FEBRUARY 2018
  • FIGURE 36: VETERINARY PAIN MANAGEMENT DRUGS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2017
  • FIGURE 37: BOEHRINGER INGELHEIM: COMPANY SNAPSHOT (2016)
  • FIGURE 38: ZOETIS: COMPANY SNAPSHOT (2016)
  • FIGURE 39: ELI LILLY AND COMPANY: COMPANY SNAPSHOT (2016)
  • FIGURE 40: MERCK ANIMAL HEALTH: COMPANY SNAPSHOT (2016)
  • FIGURE 41: BAYER: COMPANY SNAPSHOT (2016)
  • FIGURE 42: VETOQUINOL: COMPANY SNAPSHOT (2016)
  • FIGURE 43: NORBROOK LABORATORIES: COMPANY SNAPSHOT (2016)
  • FIGURE 44: CEVA SANTE ANIMALE: COMPANY SNAPSHOT (2016)
  • FIGURE 45: DECHRA PHARMACEUTICALS: COMPANY SNAPSHOT (2017)

영문목차

"Global veterinary pain management market projected to grow at a CAGR of 8.0%"

The global veterinary pain management market is projected to reach USD 1.66 billion by 2023 from USD 1.13 billion in 2018, at a CAGR of 8.0% during the forecast period. Factors such as growth in companion animal adoption, increasing number of veterinary practitioners and their rising income levels in developed economies, growing prevalence of animal diseases causing pain and inflammation, and rising adoption of pet insurance with growing animal health expenditure are expected to drive the growth of the market. However, increasing pet care cost may restrain market growth to a certain extent.

"By devices, laser therapy devices held the largest market share in 2017"

On the basis of devices, the market is segmented into laser and electromagnetic therapy devices. Laser therapy devices accounted for the largest share of the veterinary pain management devices market. The large share of this segment can be attributed to the effectiveness of laser therapy devices in curing a wide range of acute and chronic pain conditions in animals.

"By application, the cancer segment is expected to grow at the highest CAGR during the forecast period"

On the basis of application, the market is segmented into joint pain, postoperative pain, cancer, and other applications. The cancer segment is expected to grow at the highest CAGR during the forecast period. This can be attributed to the growing prevalence of cancer in companion animals and the requirement of pain management at every stage of cancer treatment.

"By animal type, the companion animal held the largest market share in 2017"

By animal type, the market is further segmented into companion and livestock. In 2017, the companion animals segmented accounted for the largest share of the veterinary pain management market due to increasing companion animal ownership, growing awareness about animal health among pet owners, and rising pet healthcare expenditure.

"North America is expected to grow at the largest share during the forecast period (2018-2023)"

North America dominated the veterinary pain management market in 2017, followed by Europe, Asia Pacific, Latin America, and the Middle East & Africa. In North America, the US is expected to hold the largest share of the veterinary pain management market due to the growing number of people adopting pets, increasing animal healthcare expenditure, growing veterinary practices, and increasing prevalence of chronic diseases such as cancer and osteoarthritis.

Break of primary participants was as mentioned below:

  • By Company Type - Tier 1-45%, Tier 2-30% and Tier 3-25%
  • By Designation - C-level-45%, Director Level-32%, Others-23%
  • By Region - North America-46%, Europe-27%, Asia-Pacific-20%, Latin America-4%, Middle East & Africa- 3%

The major players in the veterinary pain management market are: Zoetis(US), Merck Animal Health (US), Elanco (US), Chanelle (Ireland), Boehringer Ingelheim (Germany), Vetoquinol (France), Bayer (Germany), Norbrook (Ireland), Ceva Sante Animale (France), K-Laser (US), Assisi (US), and Dechra Pharmaceuticals (UK).

Research Coverage:

The veterinary pain management market in this report is segmented by product, application, animal type, distribution channel, and regions. It provides detailed information regarding major factors influencing the growth market (drivers, restraints, opportunities, and industry-specific challenges). The study tracks and analyzes competitive developments (such as partnerships, agreements, collaborations, mergers & acquisitions, new product developments, geographical expansions, and R&D activities) and strategically profiles the key players and comprehensively analyzes their market shares and core competencies in the veterinary pain management market.

Reasons to Buy the Report:

From an insight perspective, this research report has focused on various levels of analysis-market share analysis of top players, company profiles which together comprise and discuss the basic views on the competitive landscape; emerging and high-growth segments of the veterinary pain management market; high-growth regions; and market drivers, restraints, and opportunities. The report provides the latest veterinary pain industry statistics and industry trends, allowing buyers to identify the high growth product segment and potential customers and suppliers hence driving revenue growth and profitability.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on pain management products offered by the top players in the global veterinary pain management market
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the veterinary pain management market
  • Market Development: Comprehensive information about lucrative emerging markets - the report analyzes the markets for veterinary pain management market across regions
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the global veterinary pain management market
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the global veterinary pain management market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DATA
    • 2.1.1. SECONDARY SOURCES
      • 2.1.1.1. Key data from secondary sources
    • 2.1.2. PRIMARY SOURCES
      • 2.1.2.1. Key data from primary sources
      • 2.1.2.2. Key industry insights
  • 2.2. MARKET SIZE ESTIMATION
  • 2.3. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4. MARKET SHARE ESTIMATION
  • 2.5. ASSUMPTIONS FOR THE STUDY
  • 2.6. LIMITATIONS

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. VETERINARY PAIN MANAGEMENT: MARKET OVERVIEW
  • 4.2. ASIA PACIFIC: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION
  • 4.3. GEOGRAPHIC SNAPSHOT OF THE VETERINARY PAIN MANAGEMENT MARKET
  • 4.4. VETERINARY PAIN MANAGEMENT MARKET: DEVELOPING VS. DEVELOPED COUNTRIES/REGIONS
  • 4.5. VETERINARY PAIN MANAGEMENT MARKET: REGIONAL MIX

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Growth in companion animal adoption
      • 5.2.1.2. Growth in the number of veterinary practitioners and their income levels in developed economies
      • 5.2.1.3. Growing prevalence of animal diseases causing pain and inflammation
      • 5.2.1.4. Rising demand for pet insurance with growing animal health expenditure
    • 5.2.2. RESTRAINT
      • 5.2.2.1. Increasing pet care costs
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Increasing popularity of non-conventional and non-pharmaceutical treatment techniques
      • 5.2.3.2. Untapped emerging markets
    • 5.2.4. CHALLENGES
      • 5.2.4.1. Low animal healthcare awareness in emerging markets
      • 5.2.4.2. Stringent regulatory approval process for pain management drugs
  • 5.3. REGULATORY ANALYSIS

6. VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT

  • 6.1. INTRODUCTION
  • 6.2. DRUGS
    • 6.2.1. DRUGS, BY TYPE
      • 6.2.1.1. NSAIDs
      • 6.2.1.2. Opioids
      • 6.2.1.3. Local Anesthetics
      • 6.2.1.4. Alpha-2 Agonists
      • 6.2.1.5. Disease-modifying Osteoarthritis Drugs (DMOADs)
      • 6.2.1.6. Other Drugs
    • 6.2.2. DRUGS, BY ROUTE OF ADMINISTRATION
      • 6.2.2.1. Oral
      • 6.2.2.2. Parenteral
      • 6.2.2.3. Topical
  • 6.3. DEVICES
    • 6.3.1. LASER THERAPY DEVICES
    • 6.3.2. ELECTROMAGNETIC THERAPY DEVICES

7. VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION

  • 7.1. INTRODUCTION
  • 7.2. JOINT PAIN
    • 7.2.1. OSTEOARTHRITIS
    • 7.2.2. MUSCULOSKELETAL DISORDERS
  • 7.3. POSTOPERATIVE PAIN
  • 7.4. CANCER
  • 7.5. OTHER APPLICATIONS

8. VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE

  • 8.1. INTRODUCTION
  • 8.2. COMPANION ANIMALS
    • 8.2.1. DOGS
    • 8.2.2. CATS
    • 8.2.3. HORSES
    • 8.2.4. OTHER COMPANION ANIMALS
  • 8.3. LIVESTOCK
    • 8.3.1. CATTLE
    • 8.3.2. SWINE
    • 8.3.3. OTHER LIVESTOCK

9. VETERINARY PAIN MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL

  • 9.1. INTRODUCTION
  • 9.2. VETERINARY HOSPITALS & CLINICS
  • 9.3. PHARMACY

10. VETERINARY PAIN MANAGEMENT MARKET, BY REGION

  • 10.1. INTRODUCTION
  • 10.2. NORTH AMERICA
    • 10.2.1. US
    • 10.2.2. CANADA
  • 10.3. EUROPE
    • 10.3.1. GERMANY
    • 10.3.2. UK
    • 10.3.3. FRANCE
    • 10.3.4. ITALY
    • 10.3.5. SPAIN
    • 10.3.6. REST OF EUROPE (ROE)
  • 10.4. ASIA PACIFIC
    • 10.4.1. CHINA
    • 10.4.2. JAPAN
    • 10.4.3. INDIA
    • 10.4.4. REST OF ASIA PACIFIC (REST OF APAC)
  • 10.5. LATIN AMERICA
  • 10.6. MIDDLE EAST AND AFRICA

11. COMPETITIVE LANDSCAPE

  • 11.1. OVERVIEW
  • 11.2. PRODUCT PORTFOLIO MIX
  • 11.3. GROWTH STRATEGY MATRIX
  • 11.4. MARKET SHARE ANALYSIS, 2017
  • 11.5. COMPETITIVE SITUATION AND TRENDS
    • 11.5.1. ACQUISITIONS
    • 11.5.2. PRODUCT LAUNCHES
    • 11.5.3. AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
    • 11.5.4. EXPANSIONS

12. COMPANY PROFILES (Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*

  • 12.1. BOEHRINGER INGELHEIM
  • 12.2. ZOETIS
  • 12.3. ELANCO
  • 12.4. MERCK ANIMAL HEALTH
  • 12.5. BAYER
  • 12.6. VETOQUINOL
  • 12.7. NORBROOK LABORATORIES
  • 12.8. CEVA SANTE ANIMALE
  • 12.9. DECHRA PHARMACEUTICALS
  • 12.10. CHANELLE
  • 12.11. K-LASER USA
  • 12.12. ASSISI ANIMAL HEALTH

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.

13. APPENDIX

  • 13.1. INSIGHTS OF INDUSTRY EXPERTS
  • 13.2. DISCUSSION GUIDE
  • 13.3. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 13.5. AVAILABLE CUSTOMIZATIONS
  • 13.6. RELATED REPORTS
  • 13.7. AUTHOR DETAILS
Back to Top
아시아 최대 시장정보 제공
전세계에서 발행되고 있는 모든 시장조사보고서를
다루고 있습니다.
사이트에서 검색되지 않는 보고서도 문의 바랍니다.
 
BCC Research